Skip to main content
Erschienen in: Urolithiasis 5/2012

01.10.2012 | Original Paper

Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs

verfasst von: Josephine S. Gnanandarajah, Juan E. Abrahante, Jody P. Lulich, Michael P. Murtaugh

Erschienen in: Urolithiasis | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

The incidence of calcium oxalate (CaOx) urolithiasis in dogs has increased steadily over the last two decades. A potential mechanism to minimize CaOx urolithiasis is to reduce enteric absorption of dietary oxalate by oxalate-metabolizing enteric bacteria. Enteric colonization of Oxalobacter formigenes, an anaerobe which exclusively relies on oxalate metabolism for energy, is correlated with absence of hyperoxaluria or CaOx urolithiasis or both in humans and laboratory animals. We thus hypothesized that decreased enteric colonization of O. formigenes is a risk factor for CaOx urolithiasis in dogs. Fecal samples from dogs with CaOx uroliths, clinically healthy, age-, breed- and gender-matched dogs, and healthy non-stone forming breed dogs were screened for the presence of O. formigenes by quantitative PCR to detect the oxalyl CoA decarboxylase (oxc) gene, and by oxalate degrading biochemical activity in fecal cultures. Prevalence of O. formigenes in dogs with CaOx uroliths was 25%, compared to 50% in clinically healthy, age-, breed- and gender-matched dogs, and 75% in healthy non-stone forming breeds. The presence of oxc genes of O. formigenes was significantly higher in healthy non-stone forming breed dogs than in the dogs with CaOx stones. Further, dogs with calcium oxalate stones and the stone-forming breed-matched controls showed comparable levels of biochemical oxalate degrading activity. We conclude that the absence of enteric colonization of O. formigenes is a risk factor for CaOx urolithiasis.
Literatur
1.
Zurück zum Zitat Abratt VR, Reid SJ (2010) Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. Adv Appl Microbiol 72:63–87PubMedCrossRef Abratt VR, Reid SJ (2010) Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. Adv Appl Microbiol 72:63–87PubMedCrossRef
2.
Zurück zum Zitat Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV (1986) Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116:455–460PubMed Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV (1986) Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116:455–460PubMed
3.
Zurück zum Zitat Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7PubMedCrossRef Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7PubMedCrossRef
4.
Zurück zum Zitat Allison MJ, Cook HM (1981) Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate. Science 212:675–676PubMedCrossRef Allison MJ, Cook HM (1981) Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate. Science 212:675–676PubMedCrossRef
5.
Zurück zum Zitat Daniel SL, Hartman PA, Allison MJ (1987) Microbial degradation of oxalate in the gastrointestinal tracts of rats. Appl Environ Microbiol 53:1793–1797PubMed Daniel SL, Hartman PA, Allison MJ (1987) Microbial degradation of oxalate in the gastrointestinal tracts of rats. Appl Environ Microbiol 53:1793–1797PubMed
6.
Zurück zum Zitat Dawson KA, Allison MJ, Hartman PA (1980) Isolation and some characteristics of anaerobic oxalate-degrading bacteria from the rumen. Appl Environ Microbiol 40:833–839PubMed Dawson KA, Allison MJ, Hartman PA (1980) Isolation and some characteristics of anaerobic oxalate-degrading bacteria from the rumen. Appl Environ Microbiol 40:833–839PubMed
7.
Zurück zum Zitat Dobbins JW, Binder HJ (1976) Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70:1096–1100PubMed Dobbins JW, Binder HJ (1976) Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70:1096–1100PubMed
8.
Zurück zum Zitat Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847PubMedCrossRef Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847PubMedCrossRef
9.
Zurück zum Zitat Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW (2011) Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 300(3):G461–G469PubMedCrossRef Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW (2011) Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 300(3):G461–G469PubMedCrossRef
10.
Zurück zum Zitat Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW (2006) Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69:691–698PubMedCrossRef Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW (2006) Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69:691–698PubMedCrossRef
11.
Zurück zum Zitat Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276PubMedCrossRef Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276PubMedCrossRef
12.
Zurück zum Zitat Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschenes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609–3615PubMedCrossRef Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschenes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609–3615PubMedCrossRef
13.
Zurück zum Zitat Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1311PubMedCrossRef Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1311PubMedCrossRef
14.
Zurück zum Zitat Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedCrossRef Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedCrossRef
15.
Zurück zum Zitat Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW (2011) Factors related to colonization with Oxalobacter formigenes in US adults. J Endourol 25:673–679PubMedCrossRef Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW (2011) Factors related to colonization with Oxalobacter formigenes in US adults. J Endourol 25:673–679PubMedCrossRef
16.
Zurück zum Zitat Knight J, Jiang J, Wood KD, Holmes RP, Assimos DG (2011) Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Urology 78:475.e9–475.e13CrossRef Knight J, Jiang J, Wood KD, Holmes RP, Assimos DG (2011) Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Urology 78:475.e9–475.e13CrossRef
17.
Zurück zum Zitat Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef
18.
Zurück zum Zitat Lekcharoensuk C, Osborne CA, Lulich JP, Pusoonthornthum R, Kirk CA, Ulrich LK, Koehler LA, Carpenter KA, Swanson LL (2002) Associations between dry dietary factors and canine calcium oxalate uroliths. Am J Vet Res 63(3):330–337PubMedCrossRef Lekcharoensuk C, Osborne CA, Lulich JP, Pusoonthornthum R, Kirk CA, Ulrich LK, Koehler LA, Carpenter KA, Swanson LL (2002) Associations between dry dietary factors and canine calcium oxalate uroliths. Am J Vet Res 63(3):330–337PubMedCrossRef
19.
Zurück zum Zitat Lulich JP (2009) Calcium oxalate: biological behavior and risk factor management. ACVIM Forum Proceedings 27:606–607 Lulich JP (2009) Calcium oxalate: biological behavior and risk factor management. ACVIM Forum Proceedings 27:606–607
20.
Zurück zum Zitat Lulich JP, Osborne CA, Thumchai R, Lekcharoensuk C, Ulrich LK, Koehler LA, Bird KA, Swanson LL, Nakagawa Y (1999) Epidemiology of canine calcium oxalate uroliths. Identifying risk factors. Vet Clin North Am Small Anim Pract 29:113–22, xi Lulich JP, Osborne CA, Thumchai R, Lekcharoensuk C, Ulrich LK, Koehler LA, Bird KA, Swanson LL, Nakagawa Y (1999) Epidemiology of canine calcium oxalate uroliths. Identifying risk factors. Vet Clin North Am Small Anim Pract 29:113–22, xi
21.
Zurück zum Zitat Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H (2003) Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10:293–296PubMedCrossRef Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H (2003) Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10:293–296PubMedCrossRef
22.
Zurück zum Zitat Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12(4):208–213PubMedCrossRef Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12(4):208–213PubMedCrossRef
23.
Zurück zum Zitat Osborne CA, Lulich JP, Kruger JM, Ulrich LK, Koehler LA (2009) Analysis of 451,891 canine uroliths, feline uroliths, and feline urethral plugs from 1981 to 2007: perspectives from the Minnesota Urolith Center. Vet Clin North Am Small Anim Pract 39(1):183–197PubMedCrossRef Osborne CA, Lulich JP, Kruger JM, Ulrich LK, Koehler LA (2009) Analysis of 451,891 canine uroliths, feline uroliths, and feline urethral plugs from 1981 to 2007: perspectives from the Minnesota Urolith Center. Vet Clin North Am Small Anim Pract 39(1):183–197PubMedCrossRef
24.
Zurück zum Zitat Prokopovich S, Knight J, Assimos DG, Holmes RP (2007) Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 178:2186–2190PubMedCrossRef Prokopovich S, Knight J, Assimos DG, Holmes RP (2007) Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 178:2186–2190PubMedCrossRef
25.
Zurück zum Zitat Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB (2001) Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 166:1487–1491PubMedCrossRef Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB (2001) Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 166:1487–1491PubMedCrossRef
26.
Zurück zum Zitat Sidhu H, Holmes RP, Allison MJ, Peck AB (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503–1509PubMed Sidhu H, Holmes RP, Allison MJ, Peck AB (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503–1509PubMed
27.
Zurück zum Zitat Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340PubMed Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340PubMed
28.
Zurück zum Zitat Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB (1998) Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352:1026–1029PubMedCrossRef Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB (1998) Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352:1026–1029PubMedCrossRef
29.
Zurück zum Zitat Sidhu H, Enatska L, Ogden S, Williams WN, Allison MJ, Peck AB (1997) Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reaction-based detection system. Mol Diagn 2:89–97PubMedCrossRef Sidhu H, Enatska L, Ogden S, Williams WN, Allison MJ, Peck AB (1997) Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reaction-based detection system. Mol Diagn 2:89–97PubMedCrossRef
30.
Zurück zum Zitat Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef
31.
Zurück zum Zitat Wandzilak TR, Williams HE (1990) The hyperoxaluric syndromes. Endocrinol Metab Clin North Am 19(4):851–867PubMed Wandzilak TR, Williams HE (1990) The hyperoxaluric syndromes. Endocrinol Metab Clin North Am 19(4):851–867PubMed
32.
Zurück zum Zitat Weese JS, Palmer A (2009) Presence of Oxalobacter formigenes in the stool of healthy dogs. Vet Microbiol 137:412–413PubMedCrossRef Weese JS, Palmer A (2009) Presence of Oxalobacter formigenes in the stool of healthy dogs. Vet Microbiol 137:412–413PubMedCrossRef
33.
Zurück zum Zitat Weese JS, Rousseau J, Weese HE (2009) Variation in shedding of Oxalobacter formigenes in feces of healthy dogs. Vet Microbiol 139:421–422PubMedCrossRef Weese JS, Rousseau J, Weese HE (2009) Variation in shedding of Oxalobacter formigenes in feces of healthy dogs. Vet Microbiol 139:421–422PubMedCrossRef
34.
Zurück zum Zitat Weese JS, Weese HE, Rousseau J (2009) Identification of Oxalobacter formigenes in the faeces of healthy cats. Lett Appl Microbiol 49(6):800–802PubMedCrossRef Weese JS, Weese HE, Rousseau J (2009) Identification of Oxalobacter formigenes in the faeces of healthy cats. Lett Appl Microbiol 49(6):800–802PubMedCrossRef
Metadaten
Titel
Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs
verfasst von
Josephine S. Gnanandarajah
Juan E. Abrahante
Jody P. Lulich
Michael P. Murtaugh
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2012
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0451-1

Weitere Artikel der Ausgabe 5/2012

Urolithiasis 5/2012 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.